Bosworth Ailsa, Cox Maureen, O'Brien Anne, Jones Peter, Sargeant Ify, Elliott Alison, Bukhari Marwan
Ify Sargeant, Ismedica Ltd, Pine Trees, Old Road, Wrinehill, Staffordshire, CW3 9BW, UK.
Curr Rheumatol Rev. 2015;11(1):1-7. doi: 10.2174/1573397111666150522093712.
Patient experience is not routinely measured in rheumatoid arthritis (RA) and no accepted standardised Patient Reported Experience Measures (PREM) tools currently exist. Commissioning for Quality in Rheumatoid Arthritis (CQRA) has developed, piloted and validated PREMs for RA and other rheumatic conditions.
Focus groups were held with RA patients to identify key elements of the patient experience. These were mapped against the UK Department of Health Patient Experience Framework and a PREM questionnaire developed with questions specifically relating to RA and rheumatology services. The RA PREM was piloted and Cronbach's alpha used to assess internal consistency. The PREM was modified to capture experience of patients with other rheumatic conditions and further validated.
Ten UK sites and 524 patients were included in the RA PREM pilot and validation analysis. The RA PREM reliably captured RA patient experience and had good construct validity. Cronbach's alpha within the multiquestion domains ranged from 0.61 to 0.90 and the percentage agreement ranged from 22.5% to 70.4% with overall care. The modified PREM was evaluated in 11 UK sites and 110 patients with a range of rheumatic conditions. Cronbach's alpha ranged from 0.76 to 0.91 and the percentage agreement similarly ranged from 70% to 90% with the question on overall care.
The RA PREM and the modified PREM provide new valuable validated tools for capturing the patient experience in a range of rheumatic conditions. The RA PREM is currently being used in a UK National Clinical Audit of Rheumatoid and Early Inflammatory Arthritis.
类风湿关节炎(RA)患者体验未常规测量,目前也不存在被广泛认可的标准化患者报告体验测量(PREM)工具。类风湿关节炎质量委托项目(CQRA)已开发、试点并验证了针对RA及其他风湿性疾病的PREM。
与RA患者进行焦点小组讨论,以确定患者体验的关键要素。将这些要素与英国卫生部患者体验框架进行比对,并开发了一份PREM问卷,其中包含与RA和风湿病服务具体相关的问题。对RA PREM进行试点,并使用Cronbach's α系数评估内部一致性。对PREM进行修改以获取其他风湿性疾病患者的体验,并进一步验证。
RA PREM试点及验证分析纳入了英国的10个地点和524名患者。RA PREM可靠地捕捉了RA患者的体验,具有良好的结构效度。多问题领域内的Cronbach's α系数范围为0.61至0.90,与整体护理的百分比一致性范围为22.5%至70.4%。在英国的11个地点对110名患有一系列风湿性疾病的患者进行了修改后的PREM评估。Cronbach's α系数范围为0.76至0.91,与整体护理问题的百分比一致性同样范围为70%至90%。
RA PREM和修改后的PREM为获取一系列风湿性疾病患者的体验提供了新的、经过验证的有价值工具。RA PREM目前正在英国类风湿和早期炎症性关节炎国家临床审计中使用。